Is Valeo Pharma Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Valeo Pharma Inc (VPH.TO) is currently classified as NOT HALAL as of October 2023. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Valeo Pharma Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Valeo Pharma Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Valeo Pharma Inc?

Muslim investors may consider investing in Valeo Pharma Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Valeo Pharma Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Valeo Pharma Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Valeo Pharma Inc updated?

The Shariah compliance status of Valeo Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Valeo Pharma Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Valeo Pharma Inc?

You can check the latest Shariah compliance status of Valeo Pharma Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VPH.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 29, 2023

Report Source: 2023 3rd Quarter Report

Analyst's Ratings for Valeo Pharma Inc (VPH.TO)

Based on 5 analysts giving stock ratings to Valeo Pharma Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valeo Pharma Inc. Stock Analysis VPH.TO

Canada Health Care Nano Cap Report: Q3, 2023

Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. The company is headquartered in Kirkland, Quebec and currently employs 70 full-time employees. The firm acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The firm is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The firm's wholly owned subsidiary is VPI Pharmaceuticals Inc.

Key Statistics of Valeo Pharma Inc (VPH.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.05CAD0.05

Today's Open

CAD0.05

Volume

51.00K

P/E Ratio (TTM)

52 Week Range

CAD0.13CAD0.64

Market Cap

4.44M

Avg. Volume

85.78K

Dividend Yield

Financial Metrics & Statements of Valeo Pharma Inc (VPH.TO)

FAQ's for Valeo Pharma Inc (VPH.TO)

According to Musaffa’s Shariah screening methodology, Valeo Pharma Inc (VPH.TO) is currently classified as NOT HALAL as of October 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.